Vistagen Therapeutics Inc (VTGN) Net Income by Year
Vistagen Therapeutics Inc reported a net loss of $69.7M in fiscal year 2026. This represents a decrease of 35.5% from the prior fiscal year. Over the trailing 12 months, Q2 FY2026 through Q1 FY2027, the same line adds up to a $67.6M net loss. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters Vistagen Therapeutics Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
VTGN Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.
VTGN Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Vistagen Therapeutics Inc financials
Frequently Asked Questions
What was Vistagen Therapeutics Inc's net income in fiscal year 2026?
Vistagen Therapeutics Inc reported a net loss of $69.7M in fiscal year 2026.
How fast is Vistagen Therapeutics Inc's net income growing?
Vistagen Therapeutics Inc (VTGN) net income fell by 35.5% year over year, from -$51.4M to -$69.7M in fiscal year 2026.
What is Vistagen Therapeutics Inc's net income over the last twelve months?
Vistagen Therapeutics Inc (VTGN) reported a $67.6M net loss over the trailing 12 months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.
What was Vistagen Therapeutics Inc's net income in the most recent quarter?
Vistagen Therapeutics Inc (VTGN) reported -$13.0M in net income in Q1 2027. This represents an increase of 13.7% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Vistagen Therapeutics Inc (VTGN) reported on that line in every period on record.